A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma

Sci Rep. 2024 Mar 13;14(1):6134. doi: 10.1038/s41598-024-56676-0.

Abstract

Uterine corpus endometrial carcinoma (UCEC) is becoming a main malignant cancer that threaten to women's health. Thymidine kinase 1 (TK1) is considering to be associated with tumorigenesis and development. Nevertheless, the function of TK1 in UCEC is still unclear. Herein, we analyzed the TK1 expression level in pan-cancer and found that TK1 was upregulated in a variety of cancers including UCEC. Patients of UCEC with high expression of TK1 were related to poor outcome. TK1 was also related to clinical stage, histologic grade and lymph node metastasis. Abnormal expression of TK1 in UCEC was related to promoter methylation while gene mutation was not frequent. TK1 and its associated genes appeared to be prominent in cell cycle and DNA replication, according to GO and KEGG analysis. Analysis of immune infiltration revealed a negative correlation between TK1 and CD8 + T cells, macrophages, and dendritic cells. In vitro experiments, TK1 knockdown resulted in the inhibition of proliferation, migration, invasion and EMT in UCEC cell lines.

Keywords: Diagnosis; Immune; Prognosis; TK1; UCEC.

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Carcinogenesis
  • Carcinoma, Endometrioid*
  • Endometrial Neoplasms* / genetics
  • Female
  • Humans
  • Thymidine Kinase / genetics

Substances

  • thymidine kinase 1
  • Thymidine Kinase